Information Journal Paper
APA:
Copy. (2018). Baricitinib treatment in a patient with a gainof-function mutation in signal transducer and activator of transcription 1 (STAT1). JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 142(1), 328-330. SID. https://sid.ir/paper/766547/en
Vancouver:
Copy. Baricitinib treatment in a patient with a gainof-function mutation in signal transducer and activator of transcription 1 (STAT1). JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY[Internet]. 2018;142(1):328-330. Available from: https://sid.ir/paper/766547/en
IEEE:
Copy, “Baricitinib treatment in a patient with a gainof-function mutation in signal transducer and activator of transcription 1 (STAT1),” JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 142, no. 1, pp. 328–330, 2018, [Online]. Available: https://sid.ir/paper/766547/en